Variant dossier

BRAF p.G466V

Static provenance dossier for a highlighted variant. Use the linked Explore state to compare related records across the full catalog.

DriverHotspotActionable

BRAF p.G466V

No mechanism summary is present in the seed catalog for this record.

0.88%reported frequency
5samples
2sources
Coordinate
GRCh37 chr7:140,481,411
Cancer types
LUAD Lung Adenocarcinoma (TCGA, PanCancer Atlas)
Pathway
RTK-RAS
Therapy context
Vemurafenib, Dabrafenib, Encorafenib
Clinical annotation
N/A
Citations
29625048, 29596782, 29622463, 29617662, 29625055, 29625050, 30643250, 32214244, 29625049, 29850653 +1
VariantCancerEvidenceFrequencySources
BRAF p.V600E
substitution
THPADriverHotspotActionable58.0%cBioPortal, TCGA Pan-Cancer Atlas
BRAF p.V600E
substitution
SKCMDriverHotspotActionable35.9%cBioPortal, TCGA Pan-Cancer Atlas
KRAS p.G12D
substitution
PAADDriverHotspotActionable27.4%cBioPortal, TCGA Pan-Cancer Atlas
KRAS p.G12C
substitution
LUADDriverHotspotActionable12.4%cBioPortal, TCGA Pan-Cancer Atlas
KRAS p.G12V
substitution
PAADDriverHotspotActionable18.4%cBioPortal, TCGA Pan-Cancer Atlas
KRAS p.G12D
substitution
COADREADDriverHotspotActionable10.9%cBioPortal, TCGA Pan-Cancer Atlas
KRAS p.G12V
substitution
COADREADDriverHotspotActionable9.2%cBioPortal, TCGA Pan-Cancer Atlas
BRAF p.V600E
substitution
COADREADDriverHotspotActionable9.0%cBioPortal, TCGA Pan-Cancer Atlas